Results 61 to 70 of about 2,486 (97)

Navigating gastrointestinal challenges in genetic myopathies: Diagnostic insights and future directions. [PDF]

World J Methodol
Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R.   +3 more
europepmc   +1 more source

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy. [PDF]

Neurol Sci
Rimoldi M, Lucchiari S, Pagliarani S, Meola G, Comi GP, Abati E.   +5 more
europepmc   +1 more source

Socio-economic determinants of intimate-partner physical violence among women in South Africa. [PDF]

Front Psychol
Mabena K, Tsabedze W, Mazibuko X.
europepmc   +1 more source

Impact of an Educational Intervention on Public Perception of Health Problems in Brachycephalic Dogs. [PDF]

Vet Med Sci
Smith G, Wills AP.
europepmc   +1 more source

Gastrointestinal, Behaviour and Anxiety Outcomes in Autistic Children Following an Open Label, Randomised Pilot Study of Synbiotics vs Synbiotics and Gut-Directed Hypnotherapy. [PDF]

J Autism Dev Disord
Mitchell LK, Heussler HS, Burgess CJ, Rehman A, Steinert RE, Davies PSW.   +5 more
europepmc   +1 more source

Roux-en-Y Gastric Bypass Reduces Preprandial Appetite and Energy Intake Without Altering Relative Macronutrient Intake

Bueter M, Alceste D, Jucker N, Burgh Yvd, File B, Thalheimer A, Steinert R, Spector A, Maurer S, Hazebroek E, Gero D, Serra M.   +11 more
europepmc   +1 more source

The Uneven Effect of Rare Diseases on Functional Status and Work Capacity. [PDF]

Healthcare (Basel)
Oancea C, Gherman DM, Popescu FG, Aurelian SM, Homentcovschi C.   +4 more
europepmc   +1 more source

Massive Splenic Infarction: A Rare Entity in a Female Teenager. [PDF]

Cureus
Moreno Fernandes M, Rodrigues Neto M, Dias Preda A, Pena Fernandes T, Rodrigues J.   +4 more
europepmc   +1 more source

Post ingestive systemic nutrient sensing for whole-body homeostasis. [PDF]

Mol Cells
Lee G, Lee J, Suh GSB, Oh Y.
europepmc   +1 more source

Strong antagonism of an endophyte of Fraxinus excelsior towards the ash dieback pathogen, Hymenoscyphus fraxineus, is mediated by the antifungal secondary metabolite PF1140. [PDF]

Appl Environ Microbiol
Demir Ö, Schulz B, Rabsch L, Steinert M, Surup F.   +4 more
europepmc   +1 more source